MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41408-025-01391-w

Медицинская библиотека · Blood cancer journal · 2025

A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia.

Golick Lena, Robinson Reeder M, Reyes Leticia, St Thomas Nadia, Klinzing Kathleen, O'Connor Erin C, Ferreira Leonardo M R, Dolloff Nathan G

СтатьяПеревод в очереди

Аннотация

The treatment of acute myeloid leukemia (AML) remains a challenge due to disease heterogeneity, which undermines efforts to develop targeted therapeutics, leaving conventional chemotherapy as the standard of care (SOC). Sialic acid binding Ig-like lectin 3 (CD33) is a myeloid cell surface glycoprotein that is highly expressed on AML blasts. However, while ~90% of AML cases express CD33, 50% of these patients harbor a single nucleotide polymorphism (SNP) that eliminates the antibody binding epitope for existing CD33-targeted antibody therapeutics. In this study, we developed an immunotherapy (M2T-CD33) that targets CD33 directly to MHC class II (MHCII) molecules on antigen presenting cells for enhanced presentation to the immune system. We found that M2T-CD33 induces a robust polyclonal anti-CD33 humoral response composed of the full immunoglobulin repertoire. M2T-CD33 induced an anti-AML response in a syngeneic mouse model that was dependent on CD4+ and CD8+ T cells. The immune response was elicited against both the full length and spliced version of CD33 and showed no evidence of toxicity at concentrations 40-fold higher than the efficacious dose. Finally, M2T-CD33 was enhanced by combinations with anti-PD-1 therapy. These experiments demonstrate the preclinical potential of M2T-CD33 in AML and emphasize the importance of MHCII for cancer immunotherapy.

Для цитирования: Golick Lena, Robinson Reeder M, Reyes Leticia, St Thomas Nadia, Klinzing Kathleen, O'Connor Erin C, Ferreira Leonardo M R, Dolloff Nathan G. A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia.. Blood cancer journal. 2025. DOI: 10.1038/s41408-025-01391-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.